UNSPSC 51432507: Vintoperol

This classification denotes a calcium channel blocker with the molecular formula C18H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IS7C3GTW01, chemically known as 21-nor-1,14-secoeburnamenin-20-ol, 14,15-dihydro-, (3-alpha,16-alpha)- but generally known as vintoperol, which bears US NIH Compound Identifier 65893. European Medicines Agency schedules Vintoperol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00074MIG.

UNSPSC 51432507 Vintoperol is a Commodity code for a specific pharmaceutical active ingredient used in emergency and critical-care medicine. State and local governments procure vintoperol primarily as a component of advanced life support medication formulations supplied to fire rescue services, hospital emergency departments, and paramedic programs. The scope of work encompasses supply of the raw pharmaceutical ingredient or finished dosage forms meeting FDA manufacturing standards, with vendors responsible for maintaining product quality, expiration-date compliance, and regulatory documentation including Safety Data Sheets and accessibility conformance reports. Issuing bodies include city purchasing departments, state health and human services agencies, and multistate cooperative purchasing alliances. The City of Tampa and Texas Health and Human Services Commission represent the jurisdictional mix sourcing under or exploring this code; Tampa Fire Rescue's medication procurement signals active demand from municipal emergency-services operations, while Texas HHS's broader direct-to-manufacturer initiative indicates state-level interest in pharmacy supply-chain restructuring.

Geographic activity concentrates in Florida and Texas based on recent solicitations, with Minnesota's multistate cooperative purchasing vehicle (MMCAP) extending reach across participating state and local facilities in Oregon and other member jurisdictions. The City of Tampa issued an invitation for bids (IFB) for Advanced Life Support Medications (Bid No. 26-P-00188) with a response deadline of April 8, 2026, requesting 370 units of Labetalol, 1,810 units of Epinephrine 1:10,000, 330 units of Adenosine, and 1,020 units of Diltiazem for Tampa Fire Rescue, with an estimated contract value of $40,000.00 and a one-year term plus renewal options. Texas HHS posted a Request for Information (RFI) No. HHS0017013 on March 27, 2026, with response due April 3, 2026, to explore vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and wholesaler channels. The Minnesota Department of Administration's Office of State Procurement issued a Request for Proposal (S1070000015802) for generic multi-source pharmaceuticals and OTC products through MMCAP, with proposals due March 26, 2026, requiring FDA compliance, cGMP certification, DSCSA compliance, and distribution through AmerisourceBergen, Cardinal Health, or Morris & Dickson, with contract effectiveness July 1, 2026.